Regeneron Pharmaceuticals Backtested Returns
Macroaxis considers Regeneron Pharmaceuticals to be not too risky. Regeneron Pharmaceuticals
maintains Sharpe Ratio (i.e. Efficiency) of -0.0177 which implies Regeneron Pharmaceuticals
had -0.0177% of return per unit of risk over the last 1 month. Macroaxis philosophy towards forecasting risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators
. Regeneron Pharmaceuticals exposes twenty-eight different technical indicators
which can help you to evaluate volatility that cannot be diversified away. Please be advised to check Regeneron Pharmaceuticals Coefficient Of Variation
of (16,863) and Risk Adjusted Performance of 0.0037 to confirm risk estimate we provide. Macroaxis gives Regeneron Pharmaceuticals performance score of 0 on a scale of 0 to 100. The organization holds Beta of 0.1056 which implies as returns on market increase, Regeneron Pharmaceuticals returns are expected to increase less than the market. However during bear market, the loss on holding Regeneron Pharmaceuticals will be expected to be smaller as well.. Even though it is essential to pay attention to Regeneron Pharmaceuticals current trending patterns, it is always good to be careful when utilizing equity existing price patterns. Macroaxis philosophy towards forecasting future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Regeneron Pharmaceuticals exposes twenty-eight different technical indicators which can help you to evaluate its performance. Regeneron Pharmaceuticals has expected return of -0.0267%. Please be advised to check Regeneron Pharmaceuticals Downside Variance, and the relationship between Sortino Ratio and Accumulation Distribution to decide if Regeneron Pharmaceuticals past performance will be repeated at some point in the near future.
|15 days auto-correlation||(0.69) |
Very good reverse predictability
Regeneron Pharmaceuticals Inc has very good reverse predictability. Overlapping area represents the amount of predictability between Regeneron Pharmaceuticals time series from November 15, 2017 to November 30, 2017 and November 30, 2017 to December 15, 2017. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Regeneron Pharmaceuticals price movement. The serial correlation of -0.69 indicates that around 69.0% of current Regeneron Pharmaceuticals price fluctuation can be explain by its past prices. Given that Regeneron Pharmaceuticals Inc has negative autocorrelation for selected time horizon, investors may consider taking a contrarian position regarding future price movement of Regeneron Pharmaceuticals for similar time interval.
|Correlation Coefficient|| -0.69|
|Spearman Rank Test|| -0.79|
|Price Variance|| 42.39|
|Lagged Price Variance|| 138.83|
Regeneron Pharmaceuticals Lagged Returns